This inventor holds 2 USPTO granted patents. Top assignee: Institute of Nuclear Energy Research. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Da-Ming Wang: Innovator in Radiotracer Development
Introduction
Da-Ming Wang is a prominent inventor based in Taoyuan County, Taiwan. He has made significant contributions to the field of radiotracers and pharmaceutical compositions, particularly in the context of liver cancer treatment. With a total of 2 patents to his name, Wang's work is characterized by innovative approaches to medical imaging and therapeutic applications.
Latest Patents
Wang's latest patents include a precursor used for labeling hepatocyte receptors, which contains a trisaccharide and diamide dimercaptide ligand. This invention is crucial for developing radiotracers aimed at imaging or treating liver cancers. The precursor is a bifunctional compound that features a trisaccharide structure with a high affinity for asialoglycoprotein receptors (ASGPR) on hepatocyte surfaces. The diamide dimercaptide ligand reacts with radioisotopes to form neutral complexes, allowing the precursor to remain on hepatocyte surfaces for effective radioisotope labeling or treatment.
Another notable patent involves a precursor SnBZM for a dopamine receptor radiotracer. This invention simplifies the preparation method and enhances the stability of the resulting products. The precursor includes a tributyltin group (BuSn), which is easily replaceable, enabling the production of the dopamine receptor radiotracer I-IBZM at a high yield rate through a substitution reaction.
Career Highlights
Da-Ming Wang is affiliated with the Atomic Energy Council - Institute of Nuclear Energy Research, where he applies his expertise in nuclear energy and radiochemistry. His work has been instrumental in advancing the field of medical imaging and therapeutic solutions for liver cancer.
Collaborations
Wang collaborates with esteemed colleagues, including Show-Wen Liu and Yu Lung Chang, who contribute to his research endeavors and innovations in the field.
Conclusion
Da-Ming Wang's contributions to the development of radiotracers and pharmaceutical compositions highlight his role as a key innovator in medical technology. His patents reflect a commitment to improving diagnostic and therapeutic methods for liver cancer, showcasing the impact of his work on healthcare advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile